Porton Biopharma Limited Licenses Erwinase to Clinigen
Porton Biopharma Limited (“PBL”), the UK biopharmaceutical research, development and manufacturing company, announces that it...
Porton Biopharma (PBL) Brochure
Porton Biopharma (PBL) is experienced in developing, manufacturing and bringing life-saving biopharmaceutical therapeutics and vaccines to market.
The company is an expert at taking concepts from the research laboratory and progressing them through various stages of scale-up and process development to production of a good manufacturing practice (GMP) material suitable for clinical trial and licensure.
In addition, PBL manufactures the UK's anthrax vaccine, which is manufactured on behalf of the UK Government. It is supplied to the Department of Health for occupational health purposes and to the Ministry of Defence as a strategic biodefence medical countermeasure.
Download this free brochure to find out more about PBL's products.
More About This Company
PBL to Advance Anthrax Vaccine Phase 1 Clinical Trial
Porton Biopharma Ltd (PBL) has announced that it has signed a modification to its contract...
PBL to Attend Innovation in Manufacturing Through Collaboration
PBL will be attending the Innovation in Manufacturing Through Collaboration event in Darlington, UK, on...
Porton Biopharma Appoints New Apprentice
In advance of the National Apprenticeship Week, Porton Biopharma (PBL) is excited to announce that...